Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study, regressed proliferative diabetic retinopathy, very severe, severe and moderate non-prolifrative diabetic retinopathy patients who were going to have a cataract surgery, underwent a complete eye examination, OCT, FAG and color photography 2 weeks prior to their operation. All patients divided in two: 1) control group (Phyco,PCIOL), 2) triamcinolone treatment group (Phaco with PCIOL+IVT). One month after surgery a complete eye examination will be done especially; IOP and endophthalmitis. A 6 month follow-up will be done for these two groups and diabetic retinopathy progression will be checked.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Triamcinolone | Experimental | Injection of intravitreal Triamcinolone |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Triamcinolone | Drug | Injection of intravitreal Triamcinolone |
|
| Measure | Description | Time Frame |
|---|---|---|
| Macula diameter | 6th week, 3, 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Diabetic retinopathy | 6th weeks, 3 and 6 months later |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Siamak Moradian, MD | Contact | 00982122592200 | Moradian33195@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Dr. Siamak Moradian, MD | Shaheed Beheshti University Of Medical Science | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ophthalmic Research Centre | Active, not recruiting | Tehran | Tehran Province | 1666663111 | Iran | |
Not provided
Not provided
Not provided
Not provided
Not provided
| Siamak Moradian,MD |
| Active, not recruiting |
| Tehran |
| Tehran Province |
| 166666 |
| Iran |
| Recruiting | Tehran | Iran |
| ID | Term |
|---|---|
| D003930 | Diabetic Retinopathy |
| D002386 | Cataract |
| ID | Term |
|---|---|
| D012164 | Retinal Diseases |
| D005128 | Eye Diseases |
| D003925 | Diabetic Angiopathies |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D048909 | Diabetes Complications |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |
| D007905 | Lens Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D014221 | Triamcinolone |
| ID | Term |
|---|---|
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |
Not provided
Not provided